CME CME GROUP INC.
Price Chart
Executive Summary
CME Group announced a planned CEO succession: Terrence A. Duffy will transition to Executive Chairman effective March 1, 2027 (or upon filing of the 2026 10-K), and President/CFO Lynne C. Fitzpatrick will become CEO. The transition is orderly and well-telegraphed, with Duffy remaining as Executive Chairman through end of 2027 to ensure continuity. Fitzpatrick's compensation package includes a $1.2M base salary, 200% target bonus, and 700% LTI opportunity. A search for a new CFO has been initiated.
Actionable Insight
The leadership transition is orderly and well-planned, with a nine-month runway. No immediate stock catalyst. Monitor for the CFO successor announcement and any updates on the board declassification proposal from the prior DEFA14A filing. The transition should not disrupt operations given Duffy's continued presence as Executive Chairman.
Key Facts
- Terrence A. Duffy will step down as CEO and become Executive Chairman from March 2027 through December 31, 2027.
- Lynne C. Fitzpatrick, currently President and CFO, will become CEO and join the Board on the Transition Date.
- Fitzpatrick's annual base salary as CEO will be $1.2 million, with a target bonus of 200% of salary and a long-term incentive target of 700% of salary.
- Duffy's base salary remains at $2 million, with a target bonus of 200% and a 2027 equity grant of fully vested shares valued at 600% of base salary.
- The company will initiate a search for a successor CFO.
Financial Impact
No direct financial impact; compensation arrangements disclosed are standard for a $95B market cap company. Duffy's 2027 equity grant of fully vested shares at 600% of $2M base salary ($12M grant date value) and Fitzpatrick's $1.2M base salary with 700% LTI target ($8.4M) are disclosed.
Risk Factors
- Potential disruption if the CFO search takes longer than expected or if Fitzpatrick's transition faces unforeseen challenges.
- Governance uncertainty from the pending Class B shareholder vote on board declassification (adjourned meeting on June 9, 2026) could create near-term overhang.
Market Snapshot
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-273442 |
| Document: d129556dex102.htm | 0001193125-26-273442 |
| Document: d129556d8k.htm | 0001193125-26-273442 |
| Document: d129556dex991.htm | 0001193125-26-273442 |
| Document: 0001193125-26-273442-index-headers.html | 0001193125-26-273442 |
| Document: 0001193125-26-273442-index.html | 0001193125-26-273442 |
| Document: 0001193125-26-273442.txt | 0001193125-26-273442 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 18, 2026
2d ago
|
ANALYST-UPGRADE
| $247.38 awaiting T+1 | awaiting T+1 | — | $246.38 (−0.40%) |
|
Jun 17, 2026
3d ago
|
8-K
| $252.54 $246.38 | ▼ −2.44% | ▼ −3.22% | $246.38 (−2.44%) |
|
Jun 11, 2026
9d ago
|
ANALYST-UPGRADE
| $269.53 $266.08 | ▼ −1.28% | ▼ −3.04% | $246.38 (−8.59%) |
|
May 31, 2026
20d ago
|
ANALYST-UPGRADE
| $275.15 $272.55 | ▼ −0.95% | ▼ −1.18% | $246.38 (−10.46%) |
|
May 19, 2026
4w ago
|
DEFA14A
| $290.04 $289.31 | ▼ −0.25% | ▼ −0.45% | $246.38 (−15.05%) |
|
May 19, 2026
4w ago
|
Insider Cluster
| $290.04 $289.31 | ▼ −0.25% | ▼ −0.45% | $246.38 (−15.05%) |
|
Apr 22, 2026
8w ago
|
8-K
| $285.58 $285.29 | ▲ +0.10% | ▼ −0.29% | $246.38 (+13.73%) |
|
Mar 27, 2026
12w ago
|
Court Ruling
| $293.69 $297.49 | ▲ +1.29% | ▲ +1.65% | $246.38 (−16.11%) |
|
Mar 23, 2026
12w ago
|
DEFA14A
| $302.56 $293.92 | ▼ −2.86% | ▼ −3.42% | $246.38 (−18.57%) |
|
Mar 12, 2026
14w ago
|
Insider Cluster
| $311.25 $311.41 | ▼ −0.05% | ▼ −0.65% | $246.38 (+20.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access